Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Eloxx Pharmaceuticals Q2 EPS $(0.54) Down From $(0.20) YoY

Eloxx Pharmaceuticals (NASDAQ:ELOX) reported quarterly losses of $(0.54) per share. This is a 170 percent decrease over losses of $(0.20) per share from the same period last year.
byBill Haddad
August 16, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Eloxx Pharmaceuticals (NASDAQ:ELOX) reported quarterly losses of $(0.54) per share. This is a 170 percent decrease over losses of $(0.20) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Solar Capital’s Earnings: A Preview

By Benzinga Insights
Today, 5:11 AM
Solar Capital (NASDAQ:SLRC) is set to give its latest quarterly earnings report on Wednesday, 2021-11-03. Here's what investors need to know before the announcement. Analysts estimate that Solar Capital will likely report an Earnings Per Share (EPS) of $0.37

SLRC